Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Monzo

Showing results (1-10 of 112) with videos related to

Pageof 12
Sort By:
European Journal of Heart Failure|February 17, 2025
Reply to 'Concerns regarding the study on circulating GDF-15 levels and diastolic dysfunction'Luca Monzo, Nicolas Girerd
JACC. Heart Failure|April 3, 2024
Tackling the ReD(S) Flag of Congestion in Heart FailureNicolas Girerd, Luca Monzo
Heart (British Cardiac Society)|August 8, 2024
Decoding proteins in cardiometabolic disease: the power and challenges of proteomicsNicolas Girerd, Luca Monzo
JACC. Heart Failure|July 9, 2025
Reply: GDF-15 in Cardiovascular Disease: Are We at the Heart of the Energy Balance?Luca Monzo, Vojtech Melenovsky
International Journal of Cardiology|August 29, 2025
Decoding the inflammatory-metabolic code: machine learning potential for outcome prediction in heart failure with diabetesLuca Monzo, Nicolas Girerd
International Journal of Cardiology|April 11, 2025
EMPACT-ing prognosis: Tailoring SGLT2i therapy with GDF-15Luca Monzo, Nicolas Girerd
Circulation|March 13, 2023
Letter by Monzo and Melenovsky Regarding Article, "Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF"Luca Monzo, Vojtech Melenovsky
European Heart Journal Supplements : Journal of the European Society of Cardiology|March 3, 2021
The uraemic hypertensive patient: a therapeutic challenge-right you are (if you think so)Gennaro Cice, Luca Monzo, Leonardo Calo
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|September 12, 2018
An unexpected complication of a percutaneous coronary angioplastyLuca Monzo, Nino Cocco, Leonardo Calò
European Heart Journal Supplements : Journal of the European Society of Cardiology|November 16, 2022
Sodium-glucose co-transporter 2 inhibitors for the treatment of cardio-renal syndromeGennaro Cice, Leonardo Calo', Luca Monzo
Pageof 12

Showing results (1-10 of 112) with videos related to

Sort By:
Pageof 12
European Journal of Heart Failure|February 17, 2025
Reply to 'Concerns regarding the study on circulating GDF-15 levels and diastolic dysfunction'Luca Monzo, Nicolas Girerd
JACC. Heart Failure|April 3, 2024
Tackling the ReD(S) Flag of Congestion in Heart FailureNicolas Girerd, Luca Monzo
Heart (British Cardiac Society)|August 8, 2024
Decoding proteins in cardiometabolic disease: the power and challenges of proteomicsNicolas Girerd, Luca Monzo
JACC. Heart Failure|July 9, 2025
Reply: GDF-15 in Cardiovascular Disease: Are We at the Heart of the Energy Balance?Luca Monzo, Vojtech Melenovsky
International Journal of Cardiology|August 29, 2025
Decoding the inflammatory-metabolic code: machine learning potential for outcome prediction in heart failure with diabetesLuca Monzo, Nicolas Girerd
International Journal of Cardiology|April 11, 2025
EMPACT-ing prognosis: Tailoring SGLT2i therapy with GDF-15Luca Monzo, Nicolas Girerd
Circulation|March 13, 2023
Letter by Monzo and Melenovsky Regarding Article, "Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF"Luca Monzo, Vojtech Melenovsky
European Heart Journal Supplements : Journal of the European Society of Cardiology|March 3, 2021
The uraemic hypertensive patient: a therapeutic challenge-right you are (if you think so)Gennaro Cice, Luca Monzo, Leonardo Calo
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|September 12, 2018
An unexpected complication of a percutaneous coronary angioplastyLuca Monzo, Nino Cocco, Leonardo Calò
European Heart Journal Supplements : Journal of the European Society of Cardiology|November 16, 2022
Sodium-glucose co-transporter 2 inhibitors for the treatment of cardio-renal syndromeGennaro Cice, Leonardo Calo', Luca Monzo
Pageof 12